John Matthew Radak serves as Executive at INVITROGEN CORP, where they oversee executive responsibilities. Since joining the company, John Matthew Radak has executed 15 insider transactions totaling $97.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 3, 2011 involved exercising options for 153 shares valued at $0.
John Matthew Radak currently holds 20,989 shares of INVITROGEN CORP (IVGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Matthew Radak has been a net seller of IVGN stock. They have purchased $22.1K and sold $75.3K worth of shares.
John Matthew Radak's most recent insider trade was on Jan 3, 2011, when they sold 153 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $14.74 |
| Discretionary |
| Jun 10, 2010 | QDEL | $10.6K | Purchase | 1,000 | $10.61 | Discretionary |
| May 21, 2010 | QDEL | $6.9K | Award | 600 | $11.47 | Discretionary |
| May 21, 2010 | QDEL | $2.3K | Award | 200 | $11.47 | Discretionary |
| May 21, 2010 | QDEL | $2.3K | Award | 200 | $11.47 | Discretionary |
| May 21, 2010 | QDEL | $2.3K | Purchase | 200 | $11.47 | Discretionary |
| May 21, 2010 | QDEL | $2.3K | Purchase | 200 | $11.47 | Discretionary |
| May 21, 2010 | QDEL | $6.9K | Purchase | 600 | $11.47 | Discretionary |
| Mar 30, 2010 | QDEL | $0 | Award | 16,083 | $N/A | Discretionary |
| Mar 30, 2010 | QDEL | $81.5K | Disposition | 5,745 | $14.18 | Discretionary |
| Jan 18, 2010 | QDEL | $0 | Award | 9,498 | $N/A | Discretionary |
| Feb 28, 2007 | IVGN | $48.9K | Sale | 761 | $64.28 | Discretionary |
| Feb 28, 2007 | IVGN | $22.6K | Option Exercise | 761 | $29.70 | Discretionary |
| May 15, 2006 | IVGN | $26.4K | Sale | 394 | $67.05 | Discretionary |